XML 67 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Financial Information of the Parent Company (Tables)
12 Months Ended
Dec. 31, 2023
Condensed Financial Information of the Parent Company [Abstract]  
Schedule of Condensed Balance Sheets Condensed balance sheets
   December 31,   December 31, 
   2023   2022 
Assets        
Current assets:        
Cash and cash equivalents  $172,588,698   $212,388,959 
Other current assets, net   2,939,668    257,500 
Due from subsidiaries   158,603,618    114,912,019 
Total current assets   334,131,984    327,558,478 
           
Total assets  $334,131,984   $327,558,478 
           
Liabilities and Shareholders’ Equity          
           
Current liabilities:          
Deficit of investments in subsidiaries  $53,878,530   $8,626,897 
Due to subsidiaries   409,607    
-
 
Total current liabilities   54,288,137    8,626,897 
           
Total liabilities   54,288,137    8,626,897 
           
Shareholders’ equity:          
Class A ordinary share, HKD0.03 par value, 11,112,474 shares authorized, 4,989,746 and 4,725,019 shares issued, 4,726,424 and 4,700,852 shares outstanding as of December 31, 2023 and 2022, respectively(1)(2)   18,178    18,080 
Class B ordinary share, HKD0.03 par value, 1,554,192 shares authorized, issued and outstanding as of December 31, 2023 and 2022, respectively(1)   5,978    5,978 
Additional paid-in capital   397,467,795    397,620,927 
Accumulated deficit   (103,761,016)   (66,988,873)
Accumulated other comprehensive loss   (13,887,088)   (11,724,531)
Total shareholders’ equity   279,843,847    318,931,581 
Total liabilities and shareholders’ equity  $334,131,984   $327,558,478 
(1)Retrospectively adjusted for the effect of the Reverse Stock Split effected on November 20, 2022. See Note 12.
(2)As of December 31, 2023 and 2022, 263,322 and 24,167 (725,000 before the Reverse Stock Split) shares reserved for future issuance upon the vesting of RSAs granted under the 2020 Plan were considered issued but not outstanding, respectively. See Note 12.

 

Schedule of Condensed Statements of Operations And Comprehensive Income (Loss) Condensed statements of operations and comprehensive income (loss)
  

For the year
ended

December 31,

2023

  

For the year
ended

December 31,

2022

  

For the year
ended

December 31,

2021

 
Operating expenses:            
General and administrative expenses  $1,482,786   $33,796,950   $6,233,339 
Total operating expenses   1,482,786    33,796,950    6,233,339 
                
Loss from operations   (1,482,786)   (33,796,950)   (6,233,339)
                
Interest income   9,945,862    2,409,547    541,598 
Other expenses   (2,847)   (52,793)   (8,505)
Exchange gain (loss)   36,752    (67,696)   1,478,258 
Other income   
-
    
-
    18,114 
Loss on forgiveness of receivable from a subsidiary   1,600,517    
-
    
-
 
Share of income (loss) from subsidiaries   (46,869,641)   (12,380,350)   8,634,815 
                
Net income (loss)  $(36,772,143)  $(43,888,242)  $4,430,941 
                
Comprehensive income (loss)               
Net income (loss)  $(36,772,143)  $(43,888,242)  $4,430,941 
Other comprehensive income (loss):               
Foreign currency translation adjustment   (2,162,557)   (4,827,526)   751,327 
Comprehensive income (loss)  $(38,934,700)  $(48,715,768)  $5,182,268 
Schedule of Condensed Statements of Cash Flows Condensed statements of cash flows
  

For the year
ended

December 31,

2023

  

For the year
ended

December 31,

2022

  

For the year
ended

December 31,

2021

 
Cash Flows from Operating Activities:            
Net income (loss)  $(36,772,143)  $(43,888,242)  $4,430,941 
Adjustments to reconcile net income (loss) to net cash used in operating activities:               
Share of (income) loss from subsidiaries   46,869,641    12,380,350    (8,634,815)
Amortization expense   
-
    6,987,975    1,987,974 
Share-based compensation   (153,034)   3,903,970    707,000 
Loss on forgiveness of receivable from a subsidiary   1,600,517    
-
    
-
 
Impairment of intangible assets   
-
    20,738,130    
-
 
Changes in assets and liabilities:               
Due from subsidiaries   (45,292,116)   127,102,949    (195,566,806)
Other current assets, net   (2,682,168)   400,545    210,904 
Accrued liabilities and other payables   
-
    (53,603)   (7,973,877)
Due to subsidiaries   409,607    
-
    
-
 
Net Cash Provided by (Used in) Operating Activities   (36,019,696)   127,572,074    (204,838,679)
                
Cash Flows from Investing Activities               
Collections from short-term investments   
-
    15,000,000    25,835,000 
Purchases of intangible assets   
-
    (10,000,000)   
-
 
Net Cash Provided by Investing Activities   
-
    5,000,000    25,835,000 
                
Cash Flows from Financing Activities               
Proceeds from issuances of ordinary shares   
-
    
-
    254,727,705 
Net Cash Provided by Financing Activities   
-
    
-
    254,727,705 
                
Effect of Foreign Exchange on Cash and Cash Equivalents   (3,780,565)   (1,760,012)   (2,465,348)
                
Net Increase (Decrease) in Cash and Cash Equivalents   (39,800,261)   130,812,062    73,258,678 
                
Cash and Cash Equivalents at Beginning of Year   212,388,959    81,576,897    8,318,219 
                
Cash and Cash Equivalents at End of Year  $172,588,698   $212,388,959   $81,576,897 
                
Non-Cash Investing and Financing Activities:               
Issuance of vested restricted share awards  $98    232    
-